Innovative Technology Reduces Complications for Prostate Cancer Patients September 5, 2024 Treatment for prostate cancer typically requires radiation therapy. While this is often highly effective, risk of affecting non-cancerous organs like the rectum are possible. “Our team is committed to providing the best possible care for our patients,” said Urologist Ross Wopat, MD, with Samaritan Urology. “That is why we’ve adopted an innovative technology, SpaceOAR Hydrogel, which reduces exposure to non-cancerous organs during prostate radiation therapy.” SpaceOAR Hydrogel is an absorbable gel that temporarily creates space between the prostate and rectum. It is designed to reduce the radiation dose delivered to the rectum during prostate radiation therapy. “We tremendously appreciate the SpaceOar program spearheaded by Dr.Wopat,” said Radiation Oncologist Patrice McGowan, MD, with Samaritan Radiation Oncology. “During patient consultation we discuss treatment approaches, such as surgery or radiation therapy, to address their prostate cancer. If radiation is the preferred treatment option we engage Dr.Wopat to arrange for placement of SpaceOar.” Center of Excellence Earned The coordination of care between urology and radiation oncology contributes to treatment success. Patients have expressed their appreciation for this extra step, knowing the two teams prioritize safe treatment. “Using this technology lowers the chance of rectal complications later and may more quickly return patients to their pre-treatment quality of life,” Dr. Wopat said. Dr. Wopat has earned the Center of Excellence designation for his expertise and administration of SpaceOAR Hydrogel. To learn more about SpaceOAR and if this pre-treatment option is right for you, contact Samaritan Urology at 541-812-5800.
